Last Updated: Oct 03, 12:00 AM·NSE
Suven Pharmaceuticals Ltd SUVENPHAR.NS
SUVENPHAR.NS Shariah Compliance
Screening Methodology: AAOIFI
As of July 2026, Suven Pharmaceuticals Ltd is classified as halal.
HALAL
Report Source: 2025 Annual Report
Suven Pharmaceuticals Ltd. Stock Analysis SUVENPHAR.NS
Suven Pharmaceuticals Ltd. manufactures chemical products. The company is headquartered in Rangareddi, Telangana and currently employs 1,052 full-time employees. The company went IPO on 2020-03-09. The firm is engaged in the business of contract development and manufacturing organization (CDMO). The company is primarily engaged in the business of development and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The firm operates through manufacturing (CRAMS) - bulk drugs & intermediates under contract services products are developed and produced on an exclusive basis under contract manufacturing services. Its geographical segments include India, the USA, Europe, and the Rest of the world. Its manufacturing capabilities for NCEs include real-time formulation development support for adaptive clinical trials and reduced production costs with novel dosage forms that minimize R&D iteration.
Read More Suven Pharmaceuticals Ltd (SUVENPHAR.NS) Chart
Key Statistics of Suven Pharmaceuticals Ltd (SUVENPHAR.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹876.95Volume
222.40KP/E Ratio (TTM)
138.2752 Week Range
Market Cap
413.36BAvg. Volume
2.71MDividend Yield
-Financial Metrics & Statements of Suven Pharmaceuticals Ltd (SUVENPHAR.NS)
Super Investors Invested in Suven Pharmaceuticals Ltd (SUVENPHAR.NS)
FAQ's for Suven Pharmaceuticals Ltd (SUVENPHAR.NS)
- As of July 2026, Suven Pharmaceuticals Ltd SUVENPHAR.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Suven Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Suven Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Suven Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Suven Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Suven Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
